Active Ingredient(s): Vosoritide
FDA Approved: * November 19, 2021
Pharm Company: * BIOMARIN PHARM
Category: Genetic Disorders

Vosoritide, sold under the brand name Voxzogo, is a medication used for the treatment of achondroplasia.[1][2][3] The most common side effects include injection site reactions (such as swelling, redness, itching or pain), vomiting and decreased blood pressure.[1][2][3] Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth.[2] The averag... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.